Check 35,000+ stocks against 26 valuation models and 37 quality factors

Retractable Technologies Inc (RVP) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Retractable Technologies Inc $0.12, price $0.69, upside -82.7%, quality 43 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? No
Add to watchlist

Healthcare · US · ISIN US76129W1053

Thin data Sep 23, 2026

Retractable Technologies Inc

RVP · US

Weakest SetupStrongly overvalued and low quality.

!Fair value $0.1200 · Strongly overvalued (−83%)

!Quality 43/100

!Weak Growth (revenue 5y −14.1 %/yr)

!Loss-making · -16.9% net margin (TTM)

!Low debt · negative free cash flow

!Trails peers (3/11)

!Narrow moat 5/100

!Evidence only low, so the estimate is less certain

!Weak on dividend: 23 out of 100

26 models, one by oneBear $0.0600 to bull $0.1700 Growth analysisrevenue history, year by year Quality 43/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Retractable Technologies Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.5700 – $13.45 · fair‑value band $0.0600 – $0.1700 · the $0.6947 price screens above the $0.1200 fair value. Dashed = 300-day average. As of Sep 23, 2026.

Follow Retractable Technologies in your weekly email

Every Wednesday you see whether Retractable Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Stock analysis

Retractable Technologies Inc (RVP) currently trades at $0.6947, while our model-based Fair Value estimate is $0.1200, implying the stock looks roughly 479.0% overvalued today.

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $0.0600 (bear) to $0.1700 (bull), the price of $0.6947 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Retractable Technologies Inc reported revenue of $38.3M in FY2025 versus $188M in FY2021, a compound −32.9%/yr. Reported net income was −$12.6M in FY2025.

Key figures

Market cap $20.8M · P/S ratio 0.55 · EPS (TTM) $−0.2200 · Dividend yield 1.1% · Net margin −32.8% · Return on equity −8.6% · Return on assets (EBIT) 0.0% · Operating margin −85.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (medium confidence).

What moves the price

The share trades about 34% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −83%, RVP screens richer than that median.

Fair Value models

Bear $0.0600 Fair Value $0.1200 Bull $0.1700

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

Gordon GGM $0.0500 $0.0900 $0.1200 68

DDM Multi-Stage $0.0500 $0.0800 $0.1000 67

NCAV (Graham) $1.24 $1.66 $2.48 54

All 3 models by family

Dividend Discount

Gordon GGM $0.0500 $0.0900 $0.1200 68

DDM Multi-Stage $0.0500 $0.0800 $0.1000 67

Asset-Based

NCAV (Graham) $1.24 $1.66 $2.48 54

Open the full fair value analysis →

Notify me when RVP reaches fair value

Put RVP on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 43/100

Of which business quality 41 · Market factors (momentum, volatility) 30

Profitability 2

Margins and returns on capital today

Quality Growth 54

Are margins and returns improving?

Cashflow 1

Earnings quality: real cash, not paper profit

Fin. Strength 46

Balance sheet, leverage, solvency risk

Investment 100

Disciplined investing over empire-building

Low Volatility 37

Calm price path (market factor)

Momentum 33

Price trend over the last 3–12 months (market factor)

52W Momentum 16

Distance to the 52-week high (market factor)

Net Issuance 90

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100

Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Revenue growth 1 year

+15.8%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−26.1%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−14.1%

Start year 2020 (pandemic). Over 10 years: +2.6% a year

Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+5.7%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

29.4% (2020) → −52.8% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

RVP screens 479% overvalued. Compare with Intuitive Surgical, Inc →

Compare Retractable Technologies Inc with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks

Beats the industry median on 3/10 measures

Overall it trails its industry peers.

Valuation

Quality Score 43 · Bottom 25%

Fair Value upside −83% · Bottom 25%

Profitability

Return on assets −9% · Bottom 25%

Net margin (TTM) −17% · Bottom 25%

Operating margin (TTM) −86% · Bottom 25%

Growth and dividend

Revenue growth −14% · Bottom 25%

Dividend yield (TTM) 1.1% · Below median

Balance sheet

Debt / equity 0.01× · Lowest 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 0.28× · Cheapest 25%

P/S (TTM) 0.56× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 15

FUTURE (revenue growth)0 · sector 31

PAST (return on equity)0 · sector 25

HEALTH (low debt)100 · sector 96

DIVIDEND (yield)23 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Intuitive Surgical, Inc ISRG	$402.09	$353.38	−12%
EssilorLuxottica Société anonyme EL	€144.50	€158.95	+10%
Medline Inc MDLN	$34.43	$30.15	−12%
Becton, Dickinson and Company BDX	$183.00	$103.53	−43%
Alcon Inc ALC	$65.59	$39.78	−39%
ResMed Inc RMD	A$31.61	A$34.77	+10%
West Pharmaceutical Services, Inc WST	$371.09	$137.28	−63%
Sartorius Stedim Biotech S.A DIM	€206.40	€54.82	−73%
Straumann Holding STMN	CHF 97.86	CHF 45.50	−54%
Solventum Corporation SOLV	$88.75	$130.51	+47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Retractable Technologies Inc · Fair Value
$0.1200 −479%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/RVP" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Retractable Technologies Inc · Fair Value</span><br><b style="font-size:20px">$0.1200</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−479%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Retractable Technologies Inc Fair Value". https://www.fairvalue-calculator.com/stock/RVP

Frequently asked questions

Is Retractable Technologies Inc (RVP) overvalued or undervalued?

As of Sep 23, 2026, our model estimates a fair value of $0.1200 versus a price of $0.6947, about −83% upside (overvalued).

What is the fair value of RVP?

Our model-based fair value for Retractable Technologies Inc is $0.1200 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.6947.

What is the quality score of RVP?

Retractable Technologies Inc has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Retractable Technologies Inc (RVP)?

Our model-based price target is the fair value of $0.1200 (as of Sep 23, 2026) from 3 valuation models. Cautious scenario $0.0600, optimistic scenario $0.1700. It is a calculation from audited fundamentals, not an analyst target.

What is the Retractable Technologies Inc stock forecast for 2026?

Our models put fair value at $0.1200, about −83% upside versus a price of $0.6947 (overvalued). Cautious scenario $0.0600, optimistic scenario $0.1700. The calculation is refreshed regularly with new filings.

What is the revenue of Retractable Technologies Inc (RVP)?

Retractable Technologies Inc reported trailing-twelve-month revenue of about $37.1M (latest available figure, as of Sep 23, 2026).

Does Retractable Technologies Inc pay a dividend?

Retractable Technologies Inc currently shows a dividend yield of about 1.14% relative to its recent price (as of Sep 23, 2026).

What is the intrinsic value of Retractable Technologies Inc (RVP)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Retractable Technologies Inc it is $0.1200 per share (as of Sep 23, 2026), against a price of $0.6947. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).

Is Retractable Technologies Inc stock overvalued or undervalued in 2026?

As of Sep 23, 2026, RVP trades above its calculated fair value: price $0.6947, fair value $0.1200, a gap of about −83% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of RVP?

No. The price is what the market pays today ($0.6947); the fair value is what the company's own numbers justify ($0.1200). For Retractable Technologies Inc the two are $0.5747 per share apart. That gap is exactly why we show both numbers side by side.

How much is Retractable Technologies Inc worth?

The market values Retractable Technologies Inc at about $20.8M (market capitalisation, as of Sep 23, 2026). Per share that is $0.6947; our models calculate a fair value of $0.1200 per share.

What do the bullish and bearish scenarios say about RVP?

Our models span a range for Retractable Technologies Inc: cautious scenario $0.0600, base $0.1200, optimistic $0.1700 per share (as of Sep 23, 2026, price $0.6947). The range comes from different growth and margin assumptions, not from analyst opinions.

How solid is the balance sheet of Retractable Technologies Inc (RVP)?

Balance-sheet figures for Retractable Technologies Inc (as of Sep 23, 2026): return on equity −8.6%, debt of 0.01 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.

How far is RVP from its 52-week high?

Retractable Technologies Inc trades at $0.6947, about 34% below its 52-week high of $1.06 and 12% above the low of $0.6200 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.1200 is for.

Which stocks are comparable to Retractable Technologies Inc?

From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Retractable Technologies Inc stock attractive at the current price?

The data as of Sep 23, 2026: price $0.6947, calculated fair value $0.1200 (−83%), Quality Score 43/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of RVP calculated?

We run Retractable Technologies Inc through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.1200, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.1 % above its aggregate fair value. Retractable Technologies Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Retractable Technologies Inc (RVP)?

The closing price on Sep 23, 2026 was $0.6947. Our model-based fair value is $0.1200, about −83% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Retractable Technologies Inc right now?

The price sits above even our optimistic bull case ($0.1700). The favourable scenario is already priced in. Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide ($0.0600 to $0.1700). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Retractable Technologies Inc

How large is the market capitalisation of Retractable Technologies Inc (RVP)?

The market capitalisation of Retractable Technologies Inc is $20.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Retractable Technologies Inc (RVP)?

The price-to-sales ratio of Retractable Technologies Inc is 0.55 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Retractable Technologies Inc (RVP)?

Earnings per share at Retractable Technologies Inc are $−0.2200. Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Retractable Technologies Inc (RVP)?

The dividend yield of Retractable Technologies Inc is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Retractable Technologies Inc (RVP)?

The net margin of Retractable Technologies Inc is −32.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Retractable Technologies Inc (RVP)?

The return on equity (ROE) of Retractable Technologies Inc is −8.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Retractable Technologies Inc (RVP)?

On an EBIT basis the return on assets of Retractable Technologies Inc is 0.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Retractable Technologies Inc (RVP)?

The operating margin of Retractable Technologies Inc is −85.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Retractable Technologies Inc (RVP)?

Revenue at Retractable Technologies Inc is growing −13.5% versus a year earlier (3y avg −26.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Retractable Technologies Inc (RVP)?

Earnings per share at Retractable Technologies Inc are growing −66.7% versus a year earlier. How much earnings per share grew versus a year earlier.

How much free cash flow does Retractable Technologies Inc (RVP) generate?

The free cash flow of Retractable Technologies Inc is −$7.6M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net cash does Retractable Technologies Inc (RVP) hold?

Retractable Technologies Inc holds more cash than debt, $1.7M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.

Free · no account needed

Watch Retractable Technologies Inc in the live analysis

One click puts Retractable Technologies Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.